These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31979136)

  • 1. Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
    Wu X; Qu D; Weygant N; Peng J; Houchen CW
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
    Weygant N; Ge Y; Qu D; Kaddis JS; Berry WL; May R; Chandrakesan P; Bannerman-Menson E; Vega KJ; Tomasek JJ; Bronze MS; An G; Houchen CW
    Cancer Res; 2016 Jul; 76(14):4090-9. PubMed ID: 27287716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.
    Cao Z; Weygant N; Chandrakesan P; Houchen CW; Peng J; Qu D
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Velázquez-Enríquez JM; Cerna R; Beltrán-Ramírez O; Piña-Vázquez C; Villa-Treviño S; Vásquez-Garzón VR
    Biochem Genet; 2024 Dec; 62(6):4280-4302. PubMed ID: 38294590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCLK1 and tuft cells: Immune-related functions and implications for cancer immunotherapy.
    Ding L; Weygant N; Ding C; Lai Y; Li H
    Crit Rev Oncol Hematol; 2023 Nov; 191():104118. PubMed ID: 37660932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    Tao H; Tanaka T; Okabe K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lived intestinal tuft cells serve as colon cancer-initiating cells.
    Westphalen CB; Asfaha S; Hayakawa Y; Takemoto Y; Lukin DJ; Nuber AH; Brandtner A; Setlik W; Remotti H; Muley A; Chen X; May R; Houchen CW; Fox JG; Gershon MD; Quante M; Wang TC
    J Clin Invest; 2014 Mar; 124(3):1283-95. PubMed ID: 24487592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of DCLK1 in cancer and cancer stem cells.
    Chhetri D; Vengadassalapathy S; Venkadassalapathy S; Balachandran V; Umapathy VR; Veeraraghavan VP; Jayaraman S; Patil S; Iyaswamy A; Palaniyandi K; Gnanasampanthapandian D
    Front Mol Biosci; 2022; 9():965730. PubMed ID: 36250024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.
    Li L; Bellows CF
    Chin J Cancer Res; 2013 Apr; 25(2):134-42. PubMed ID: 23592893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells.
    Carli ALE; Afshar-Sterle S; Rai A; Fang H; O'Keefe R; Tse J; Ferguson FM; Gray NS; Ernst M; Greening DW; Buchert M
    Proteomics; 2021 Jul; 21(13-14):e2000098. PubMed ID: 33991177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity.
    Ding L; Yang Y; Ge Y; Lu Q; Yan Z; Chen X; Du J; Hafizi S; Xu X; Yao J; Liu J; Cao Z; Weygant N
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.
    Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S
    Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma.
    Kadletz L; Thurnher D; Wiebringhaus R; Erovic BM; Kotowski U; Schneider S; Schmid R; Kenner L; Heiduschka G
    Oral Oncol; 2017 Apr; 67():109-118. PubMed ID: 28351564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma.
    Ge Y; Liu H; Zhang Y; Liu J; Yan R; Xiao Z; Fan X; Huang X; An G
    Transl Oncol; 2022 Mar; 17():101317. PubMed ID: 34998236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
    Westphalen CB; Quante M; Wang TC
    Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability.
    Lu Y; Maruyama J; Kuwata K; Fukuda H; Iwasa H; Arimoto-Matsuzaki K; Sugimura H; Hata Y
    Biochem Biophys Rep; 2018 Dec; 16():130-137. PubMed ID: 30417131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
    Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P
    Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.